BioSpace News Archive

Job Trends

Leiters Partners with Hibernation Therapeutics to Provide Adenocaine™ Cardioplegic Solution

Leiters, a trusted FDA-registered 503B provider of high-quality compounded sterile preparations, announced that it has entered into a national agreement with Hibernation Therapeutics to provide a patented cardioplegic solution developed by Hibernation Therapeutics known as Adenocaine™.

December 19, 2019
·
3 min read
BioMidwest

Blue Cross and Blue Shield of Minnesota Awards Nearly $2.5 Million to Build Community Capacity and Advance Health Equity

The Center for Prevention at Blue Cross and Blue Shield of Minnesota has awarded nearly $2 million in funding to 15 organizations from across Minnesota as a part of the Health POWER program, and nearly $500,000 to three organizations working towards systems change related to health equity.

December 19, 2019
·
4 min read
Genetown

Flagship Unveils Newest Pioneering Platform: Ring Therapeutics

New Company Is First to Harness the Human Commensal Virome for the Development of Novel DNA and Gene Therapies

December 19, 2019
·
6 min read
Drug Development

Citius Announces Positive Outcome of Interim Futility Analysis for its Phase 3 Mino-Lok® Pivotal Trial

Data Monitoring Committee recommends continuation of the trial with no changes

December 19, 2019
·
5 min read
Genetown

KCR adopts Veeva Vault Clinical Suite

The robust cloud platform will allow enhanced integration of trial management and documentation services through these new CTMS and eTMF solutions.

December 19, 2019
·
2 min read
Drug Development

Aldeyra Therapeutics Announces First Patient Enrolled in the Phase 3 GUARD Trial for Prevention of Proliferative Vitreoretinopathy

Aldeyra Therapeutics, Inc. announced enrollment of the first patient into the Phase 3 GUARD Trial of ADX-2191 for the prevention of proliferative vitreoretinopathy.

December 19, 2019
·
6 min read
Drug Development

Selecta Biosciences Announces Completion of Enrollment in Head-to-Head COMPARE Trial of SEL-212

Selecta Biosciences, Inc., a clinical-stage biotechnology company focused on unlocking the full potential of biologic therapies based on its immune tolerance platform technology, ImmTOR™, announced the completion of patient enrollment in the six-month, head-to-head, Phase 2 COMPARE clinical trial.

December 19, 2019
·
8 min read
111 Inc. Hosts 2019 Online Pharmaceuticals and Healthcare Summit

Building an Omni-Channel Commerce Platform for an Era of Drug Innovation

December 19, 2019
·
8 min read
Business

Eyenovia Expands Scientific Advisory Board with Two Experts in Optometry

Eyenovia, Inc. announced that Professor Mark Bullimore, PhD and April Jasper, OD have joined Eyenovia’s Scientific Advisory Board.

December 19, 2019
·
7 min read
Biotech Bay

Ultragenyx to Present at 38ᵗʰ Annual J.P. Morgan Healthcare Conference

Ultragenyx Pharmaceutical Inc. announced that Emil D. Kakkis, M.D., Ph.D., the company’s Chief Executive Officer and President, will present at the 38th Annual J.P. Morgan Healthcare Conference on Tuesday, January 14, 2020 at 12:00 pm PT in San Francisco..

December 19, 2019
·
1 min read